{
    "2018-04-09": [
        [
            {
                "time": "",
                "original_text": "健帆生物：预计一季度净利润同比增长40%-60%",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "一季度",
                        "净利润",
                        "同比增长",
                        "40%-60%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报：国务院发文促进仿制药发展 关注仿创优质标的",
                "features": {
                    "keywords": [
                        "医药生物",
                        "行业周报",
                        "国务院",
                        "发文",
                        "仿制药",
                        "发展",
                        "仿创优质标的"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}